To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Viral RNA polymerase PA subunit; viral RNA polymerase PB1 subunit

Infectious disease

INDICATION: Influenza virus

In vitro studies suggest inhibitors of interactions between influenza viral RNA polymerase PA and PB1 subunits could help treat

Read the full 225 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE